Zuranolone is a novel, rapidly acting, oral medication for the treatment of postpartum depression. Zuranolone is generally ...

A new UT Austin clinical trial is testing a fast‑acting treatment for postpartum depression that doesn’t require drugs, anesthesia, or talk therapy. The therapy — known as SAINT neuromodulation — uses ...

A faster treatment for postpartum depression is entering clinical trials at the University of Texas at Austin. It doesn’t ...

The University of Texas at Austin was one of four selected to participate in a $11.6 million study to help treat postpartum ...

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for ...

Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks as she imagined that something bad was going to happen to her baby, and ...

The University of Texas at Austin is one of four sites selected to participate in the $11.6 million study, funded by the U.S.

SAN FRANCISCO, California -- For the first time, the FDA has approved a medication specifically to treat new mothers who suffer from postpartum depression. The drug is called Brexanolone and will be ...

The first oral pill approved in the United States to treat postpartum depression is now available by prescription, according to the drugmakers. The US Food and Drug Administration approved the therapy ...

SCIENTISTS ARE LOOKING AT THE PSYCHEDELIC DRUG AS A TREATMENT FOR POSTPARTUM DEPRESSION. WESH 2 NEWS JILLIAN CAMPBELL TALKED WITH A MOM AND DOCTORS WHO SAY THIS COULD BE THE MEDICINE OF THE FUTURE.